Most Popular Choices
Share on Facebook 28 Printer Friendly Page More Sharing
OpEdNews Op Eds   

The Ivermectin Story

By       (Page 1 of 2 pages)   16 comments
Message Joel Hirschhorn
Become a Fan
  (20 fans)

The unrelenting opposition to using ivermectin to treat and prevent COVID-19 is stronger than ever. This has resulted from a gigantic increase in demand for IVM by much of the public. Despite big media tirades against IVM, the truth about its effectiveness (together with failure of COVID vaccines) has reached the public through many articles on alternative news websites and truth-tellers on countless podcasts. Its success has forced Big Pharma to create expensive copies of it.

Monthly IVM prescriptions increased 72 percent from 39,864 in 2019 to 68,428 in 2021 (through May). Just when COVID vaccination started to be pushed in January 2021 prescriptions hit a high of 97,192. A number of medical specialties greatly increased off-label use of IVM for fighting COVID in this period: anesthesiology, 1,319%; pulmonology, 1,167%; cardiology, 741%, for example. Strong support by physicians for IVM to cure and prevent COVID.

And in my book Pandemic Blunder I made the case with data that using cheap, safe and effective generics like IVM and hydroxychloroquine would save 80% or more of COVID deaths. Esteemed physician Peter McCollough later said 85%. For the US, that means some 600,000 lives could have been saved, and globally over 4 million lives. Meanwhile, hundreds of thousands of people worldwide have also died from COVID vaccines, the failed solution to the pandemic.

Merck, a maker of IVM, is getting much positive press coverage for its forthcoming prescription oral antiviral (molnupiravir). It is designed to replace IVM that they cannot make big money from. FDA will soon give it emergency use authorization because of the emerging clarity that COVID vaccines do NOT work effectively or safely.

That the Washington Post says that what Merck has created is the "first covid-fighting pill" illustrates how awful big media has been in ignoring the proven benefits of the IVM and HCQ generics. And ignoring the many failures of COVID vaccines. In its October 2 front-page story on the new Merck pill, it did not even mention IVM or present any data showing IVM as proven even more effective than the new expensive drug tested on only hundreds of people for a short period. In contrast, IVM has been used successfully on hundreds of thousands of people to treat and prevent COVID.

Speaking as someone who is using IVM as a prophylactic, here is what I have seen in recent times. Though getting a prescription for it is very difficult and stressful it can be done through a number of websites. But then the battle just begins. Many pharmacies, especially big chain ones, will not fill IVM prescriptions if there is any evidence that it is being used to fight COVID. And then you will likely discover, as I did, that virtually no pharmacy (typically small community ones) that will fill such prescriptions has any IVM. That's right. There is a national shortage of IVM because of huge demand in recent months and because US makers have not escalated production.

Probably, millions of vaccine resisters are using IVM, especially those resisting booster shots.

Can you still get it? Yes, and even without a prescription. It will have to come from India, with many makers of IVM. It can take many weeks to get it. But the cost is a tiny fraction of what US pharmacies have been charging when they did have it in stock. Rather than $4 or $5 for a 3 mg pill, you can buy 12 mg pills for way under $1 a pill.

But there is more to the IVM story.

There is absolutely no doubt whatsoever that there is massive medical science data showing absolute reliable data that IVM is safe and effective for both treating and preventing COVID. This is what should be a bold large headline in newspapers if we had honest big media: IVM SAFE AND EFFECTIVE ALTERNATIVE TO COVID VACCINES.

But instead, there is a constant barrage of articles and statements from government agencies asserting IVM should not be used to fight COVID. They argue it is unsafe and ineffective. Both are lies aimed solely at protecting the mass vaccination effort and the profits of big drug companies. And now protecting the new Big Pharma market for antiviral pills.

FDA has issued very strong warnings against using IVM for COVID. Nothing it has said follows the true science and mountains of data supporting safe and effective IVM use. Like other IVM opponents, it has conflated personal IVM use with the use of IVM products designed for animals.

This is even more infuriating. Merck, despite being a maker of IVM discredited its use for COVID by irresponsibly stating, "We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information."

Clearly, Merck, Pfizer and other vaccine makers are developing their own oral antivirals to directly compete with the cheap and effective IVM. These antivirals, unlike cheap generic IVM, would be patented so expensive pills could be sold worldwide. They will find some ingenious ways to copy IVM but make enough changes to get patents.

Already, Merck has begun production of its new pill to be taken twice daily for five days. Even more significant: The US government has made an advance purchase of 1.7 million treatment courses for $1.2 billion! That is over $700 per treatment. So much more profitable than making IVM. Forget the billions of dollars spent on vaccines that are injuring and killing many people.

I am confident in predicting that as more and more bad news about the ineffectiveness and dangerous side effects of COVID vaccines become increasingly known to more of the public, the big drug companies will increasingly switch from vaccines to prescription antiviral medicines. This is what smart corporate business strategic planning is all about. With Merck, it has already started. And FDA, CDC and NIH will go along with this strategic switch.

Next Page  1  |  2

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Must Read 1   Interesting 1   Valuable 1  
Rate It | View Ratings

Joel Hirschhorn Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Joel S. Hirschhorn is the author of Pandemic Blunder: Fauci and Public Health Blocked Early Home COVID Treatment, Delusional Democracy - Fixing the Republic Without Overthrowing the Government and several other books, as well as hundreds of (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Americans Unready to Revolt, Despite Revolting Conditions

9/11 Truth Manifesto

Entering a Hospital and On Medicare? The One Question You Must Always Ask

Tea Party Terrorists

The Most Powerful People in America

Fight Economic Oppression, Target the Top One Percent

To View Comments or Join the Conversation:

Tell A Friend